LONDON (Reuters) - Britain’s Orchard Therapeutics, which has already raised more than $140 million to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of GlaxoSmithKline (GSK.L) …
GSK Consumer Healthcare Ltd., (GSK) a public listed company on the Bombay Stock Exchange and National Stock Exchange, is an associate of GlaxoSmithKline. The strategic review will include an assessment of GSK’s 72.5% …
StockMarketWire.com - GlaxoSmithKline Tuesday announced that it has reached an agreement with Novartis to buy Novartis' 36.5% stake in their consumer healthcare joint venture for $13bn. As a result of the transaction, GSK's …
In India, these products are sold by GlaxoSmithKline Consumer Healthcare Ltd, a public company listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). The strategic review will include an assessment of …
The company is currently under investigation in China. GlaxoSmithKline shares were down 7 cents, or 0.13%, during pre-market trading Friday. The stock is down 1.25% YTD. Shares of GlaxoSmithKline plc (GSK) have a 4.68% yield …
LONDON (Reuters) - Britain’s Orchard Therapeutics, which has already raised more than $140 million (98.54 million pounds) to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of …